ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $74,781,843 | -27.2% | 2,783,098 | -3.4% | 0.01% | -27.3% |
| Q2 2023 | $102,733,393 | +39.0% | 2,880,914 | -1.0% | 0.01% | +22.2% |
| Q1 2023 | $73,913,000 | +64501.9% | 2,909,965 | +3.2% | 0.01% | -40.0% |
| Q4 2022 | $114,413 | -99.9% | 2,820,822 | -2.5% | 0.02% | +7.1% |
| Q3 2022 | $95,599,000 | -9.2% | 2,892,521 | -3.3% | 0.01% | -6.7% |
| Q2 2022 | $105,306,000 | -21.6% | 2,990,815 | +2.4% | 0.02% | -6.2% |
| Q1 2022 | $134,334,000 | -32.0% | 2,920,953 | -2.0% | 0.02% | -30.4% |
| Q4 2021 | $197,511,000 | +11.4% | 2,979,064 | +4.9% | 0.02% | +4.5% |
| Q3 2021 | $177,253,000 | -19.1% | 2,839,242 | +7.3% | 0.02% | -15.4% |
| Q2 2021 | $219,145,000 | +28.4% | 2,646,045 | +2.8% | 0.03% | +13.0% |
| Q1 2021 | $170,611,000 | -7.7% | 2,572,922 | +6.8% | 0.02% | -14.8% |
| Q4 2020 | $184,891,000 | +190.3% | 2,409,631 | +64.3% | 0.03% | +145.5% |
| Q3 2020 | $63,680,000 | +250.8% | 1,466,619 | +248.9% | 0.01% | +175.0% |
| Q2 2020 | $18,153,000 | +52.4% | 420,304 | +1.5% | 0.00% | +33.3% |
| Q1 2020 | $11,909,000 | -67.2% | 413,937 | -27.7% | 0.00% | -57.1% |
| Q4 2019 | $36,323,000 | +168.5% | 572,640 | +19.3% | 0.01% | +133.3% |
| Q3 2019 | $13,527,000 | +48.9% | 480,034 | +52.3% | 0.00% | +50.0% |
| Q2 2019 | $9,083,000 | +63.2% | 315,152 | +3.9% | 0.00% | +100.0% |
| Q1 2019 | $5,564,000 | +42.1% | 303,245 | -3.9% | 0.00% | 0.0% |
| Q4 2018 | $3,916,000 | -30.9% | 315,391 | +6.6% | 0.00% | 0.0% |
| Q3 2018 | $5,670,000 | +2262.5% | 295,761 | +1573.3% | 0.00% | – |
| Q2 2018 | $240,000 | -73.6% | 17,675 | -92.9% | 0.00% | – |
| Q4 2017 | $910,000 | +7483.3% | 247,380 | +3286.9% | 0.00% | – |
| Q2 2017 | $12,000 | -98.1% | 7,304 | -98.2% | 0.00% | – |
| Q4 2016 | $631,000 | -94.2% | 406,900 | -72.7% | 0.00% | -100.0% |
| Q3 2016 | $10,967,000 | +39.4% | 1,492,159 | +0.9% | 0.00% | +50.0% |
| Q2 2016 | $7,869,000 | – | 1,479,350 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,328 | $51,213,000 | 30.37% |
| JOHNSON & JOHNSON | 3,260,869 | $203,576,000 | 17.86% |
| ACT CAPITAL MANAGEMENT, LLC | 194,000 | $12,111,000 | 6.28% |
| Aquilo Capital Management, LLC | 527,926 | $32,958,000 | 5.99% |
| Evolutionary Tree Capital Management, LLC | 105,491 | $6,586,000 | 2.92% |
| ACUTA CAPITAL PARTNERS, LLC | 121,500 | $7,585,000 | 2.68% |
| L1 Capital Pty Ltd | 297,915 | $18,599,000 | 2.31% |
| Avidity Partners Management LP | 673,700 | $42,059,000 | 0.93% |
| Hood River Capital Management LLC | 338,734 | $21,147,000 | 0.65% |
| Tygh Capital Management, Inc. | 64,127 | $4,003,000 | 0.54% |